BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33845078)

  • 1. HOPX Exhibits Oncogenic Activity during Squamous Skin Carcinogenesis.
    Pavlova O; Lefort K; Mariotto A; Huber M; Hohl D
    J Invest Dermatol; 2021 Oct; 141(10):2354-2368. PubMed ID: 33845078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOPX is methylated and exerts tumour-suppressive function through Ras-induced senescence in human lung cancer.
    Chen Y; Yang L; Cui T; Pacyna-Gengelbach M; Petersen I
    J Pathol; 2015 Feb; 235(3):397-407. PubMed ID: 25345926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOPX functions as a tumour suppressor in head and neck cancer.
    Yap LF; Lai SL; Patmanathan SN; Gokulan R; Robinson CM; White JB; Chai SJ; Rajadurai P; Prepageran N; Liew YT; Lopes V; Wei W; Hollows RJ; Murray PG; Lambert DW; Hunter KD; Paterson IC
    Sci Rep; 2016 Dec; 6():38758. PubMed ID: 27934959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homeobox gene HOPX is epigenetically silenced in human uterine endometrial cancer and suppresses estrogen-stimulated proliferation of cancer cells by inhibiting serum response factor.
    Yamaguchi S; Asanoma K; Takao T; Kato K; Wake N
    Int J Cancer; 2009 Jun; 124(11):2577-88. PubMed ID: 19173292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis.
    Waraya M; Yamashita K; Katoh H; Ooki A; Kawamata H; Nishimiya H; Nakamura K; Ema A; Watanabe M
    BMC Cancer; 2012 Sep; 12():397. PubMed ID: 22958219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOPX: The Unusual Homeodomain-Containing Protein.
    Mariotto A; Pavlova O; Park HS; Huber M; Hohl D
    J Invest Dermatol; 2016 May; 136(5):905-911. PubMed ID: 27017330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer.
    Katoh H; Yamashita K; Waraya M; Margalit O; Ooki A; Tamaki H; Sakagami H; Kokubo K; Sidransky D; Watanabe M
    Neoplasia; 2012 Jul; 14(7):559-71. PubMed ID: 22904674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer.
    Kikuchi M; Katoh H; Waraya M; Tanaka Y; Ishii S; Tanaka T; Nishizawa N; Yokoi K; Minatani N; Ema A; Kosaka Y; Tanino H; Yamashita K; Watanabe M
    Cancer Lett; 2017 Jan; 384():70-78. PubMed ID: 27756570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VILIP-1 expression in vivo results in decreased mouse skin keratinocyte proliferation and tumor development.
    Fu J; Jin F; Zhang J; Fong K; Bassi DE; Lopez De Cicco R; Ramaraju D; Braunewell KH; Conti C; Benavides F; Klein-Szanto AJ
    PLoS One; 2010 Apr; 5(4):e10196. PubMed ID: 20419170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
    Bowden GT; Schneider B; Domann R; Kulesz-Martin M
    Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOPX regulates bone marrow-derived mesenchymal stromal cell fate determination via suppression of adipogenic gene pathways.
    Hng CH; Camp E; Anderson P; Breen J; Zannettino A; Gronthos S
    Sci Rep; 2020 Jul; 10(1):11345. PubMed ID: 32647304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer.
    Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Kokubo K; Kobayashi H; Kim MS; Sidransky D; Watanabe M
    Oncogene; 2010 Jun; 29(22):3263-75. PubMed ID: 20228841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro.
    Cheung BB; Koach J; Tan O; Kim P; Bell JL; D'andreti C; Sutton S; Malyukova A; Sekyere E; Norris M; Haber M; Kavallaris M; Cunningham AM; Proby C; Leigh I; Wilmott JS; Cooper CL; Halliday GM; Scolyer RA; Marshall GM
    J Pathol; 2012 Feb; 226(3):451-62. PubMed ID: 22009481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the homeobox gene, HOPX, is modulated by cell differentiation in human keratinocytes and is involved in the expression of differentiation markers.
    Yang JM; Sim SM; Kim HY; Park GT
    Eur J Cell Biol; 2010 Jul; 89(7):537-46. PubMed ID: 20226564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma.
    Ren X; Yang X; Cheng B; Chen X; Zhang T; He Q; Li B; Li Y; Tang X; Wen X; Zhong Q; Kang T; Zeng M; Liu N; Ma J
    Nat Commun; 2017 Feb; 8():14053. PubMed ID: 28146149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas.
    Botti E; Spallone G; Moretti F; Marinari B; Pinetti V; Galanti S; De Meo PD; De Nicola F; Ganci F; Castrignanò T; Pesole G; Chimenti S; Guerrini L; Fanciulli M; Blandino G; Karin M; Costanzo A
    Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13710-5. PubMed ID: 21807998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
    DeYoung MP; Johannessen CM; Leong CO; Faquin W; Rocco JW; Ellisen LW
    Cancer Res; 2006 Oct; 66(19):9362-8. PubMed ID: 17018588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma.
    Huang Y; Yang Q; Zheng Y; Lin L; Xu X; Xu XE; Silva TC; Hazawa M; Peng L; Cao H; Ding Y; Lu D; Berman BP; Xu LY; Li EM; Yin D
    Nucleic Acids Res; 2021 Sep; 49(16):9246-9263. PubMed ID: 34370013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-3-Phosphoserine phosphatase (PSPH) regulates cutaneous squamous cell carcinoma proliferation independent of L-serine biosynthesis.
    Bachelor MA; Lu Y; Owens DM
    J Dermatol Sci; 2011 Sep; 63(3):164-72. PubMed ID: 21726982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pluripotency factor NANOG promotes the formation of squamous cell carcinomas.
    Palla AR; Piazzolla D; Alcazar N; Cañamero M; Graña O; Gómez-López G; Dominguez O; Dueñas M; Paramio JM; Serrano M
    Sci Rep; 2015 May; 5():10205. PubMed ID: 25988972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.